Disrupting a destructive duo: Researchers inhibit cancer proteins

Aug 20, 2009

A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.

Working with scientists at the University of Central Florida and the Princess Margaret Hospital, Professor Patrick Gunning of the Department of Chemical and Physical Sciences has created several molecules that inhibit Stat3, a protein that--in cancer cells--pairs with another copy of itself and goes haywire. The findings appear in the September issue of the journal ChemBioChem: A European Journal of .

"The molecules we have created are particularly nice because they're showing selectivity against but not against healthy cells," says senior author Gunning. "This molecule could be used in conjunction with typical chemotherapeutics, and it could mean that drugs will have less resistance—so you could use lower dosages and cause fewer side effects."

The Stat3 protein is involved in almost all cancers, and is known to contribute to the resistance of cancer cells to current drug therapies. "Most currently available therapeutics aim to induce cell death," says Gunning. "We wanted to make small molecules that could try and stop this protein."

In cancerous cells, Stat3 proteins bind together to work as a lethal pair, and inhibitors work to prevent this. This type of protein-protein interaction is notoriously difficult to counter. Gunning's team targeted binding "hotspots" on a known Stat3 inhibitor called S3I-201. They chemically altered the inhibitor to produce several new variants, which they then tested on Stat3.

In in vitro studies, some variants proved to be even more powerful than S3I-201, and showed activity against prostate, breast and cancer cell lines. "These are some of the most potent inhibitors in the literature so far for this particular protein," says Gunning. "In some cases, they were more than twice as effective as the existing inhibitor."

When the team used more complex cancer cell models, they found the inhibitors survived the passage across the cell membrane and still targeted the Stat3 proteins inside. Gunning and his colleagues are working to make the new inhibitors even more effective, as well as more metabolically stable, meaning that they can survive the chemical defense mechanisms within the cell.

Source: University of Toronto (news : web)

Explore further: Structure of sodium channels different than previously believed

add to favorites email to friend print save as pdf

Related Stories

Blocking signaling protein prevents prostate cancer spread

Jun 02, 2008

Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have shown that by blocking a signaling protein, they can prevent prostate cancer cells from metastatic dissemination. The work opens the door to future ...

STAT3 gene regulates cancer stem cells in brain cancer

Aug 10, 2009

In a study published online in advance of print in Stem Cells, Tufts researchers report that the STAT3 gene regulates cancer stem cells in brain cancer. Cancer stem cells have many characteristics of stem c ...

Small molecules block cancer gene

Mar 10, 2009

Finding molecules that block the activity of the oncogene Stat 3 (signal transducer and activator of transcription) required screening literally millions of compounds, using computers that compared the structure of the cancer-causing ...

Inflammation directly linked to colon cancer

Feb 02, 2009

While chronic inflammation is widely believed to be a predisposing factor for colon cancer, the exact mechanisms linking these conditions have remained elusive. Scientists at the Melbourne Branch of the international Ludwig ...

Recommended for you

Breakthrough points to new drugs from nature

Apr 16, 2014

Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs.

World's first successful visualisation of key coenzyme

Apr 16, 2014

Japanese researchers have successfully developed the world's first imaging method for visualising the behaviour of nicotine-adenine dinucleotide derivative (NAD(P)H), a key coenzyme, inside cells. This feat ...

User comments : 0

More news stories

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.